Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Sumana Sharma

Group Leader: Wellcome Career Development Fellow

My research focuses on how T cells signal and how these pathways can be precisely manipulated to engineer designer immune phenotypes.

I completed my PhD in Prof. Gavin Wright’s lab at the Wellcome Sanger Institute, University of Cambridge, where I developed a genetic screening approach using CRISPR to identify receptor-ligand interactions on the cell surface. I then joined Evangelia Petsalaki’s group at EMBL-EBI for a computational postdoc, where I conceived a computational analysis tool (“CEN-tools”) using publicly available CRISPR essentiality datasets to define core and context-dependent genes in cancer. I subsequently moved to the MRC-TIDU as a Sir Henry Wellcome Postdoctoral Fellow in Prof. Simon Davis’ T Cell Biology group, where I developed genetic screening approaches to study signaling in T cells.

In 2025, I was awarded a Wellcome Career Development Award to start my group at MRC-TIDU, focused on developing new strategies for next-generation T cell immunotherapies. Our team is particularly interested in inhibitory receptor signaling in T cells and how it can be rewired to overcome immune suppression and enhance therapeutic efficacy. We use a multidisciplinary approach that combines omics technologies, CRISPR-based functional genomics, computational analysis, and primary T cell editing to uncover and exploit key regulatory mechanisms.


Key publications

Recent publications

More publications